Empowering women scientists in MENA

Funded by the Islamic Development Bank and the Bill & Melinda Gates Foundation, an international center for agriculture is promising to lay the ground work for a women empowerment initiative aimed at scientists, reportedly the first of its kind in the Middle East and North Africa (MENA) region.

The International Center for Biosaline Agriculture (ICBA) launched the design phase of the Young Arab Women Scientists Leadership Programme, dubbed Tamkeen (literally meaning empowerment in Arabic) this month.

Nature Middle East speaks to Setta Tutundjian, director of partnerships and knowledge management at ICBA, about the potential of this gender-specific science programme.

NME: How will your programme empower women involved in scientific research across the Middle East?

Setta Tutundjian: The objective of the Tamkeen program is to encourage young Arab women scientists to pursue a life-long career within the field of scientific research and development. The programme also aims to help women scientists interested in pursuing leadership positions to acquire the skills necessary to assume such leadership position within research institutes across the region.

The programme will develop  leadership and soft skills among participants in key areas such as negotiation, human resource management, science writing, proposal writing, planning, presentation, mentoring, deeper understanding of self-esteem and so on.

We expect this to be achieved through a careful mix of classroom training, online training, coaching and mentoring.

NME: You’re still designing the programme, correct?

ST: Yes. And a critical part of this phase includes conducting focus group discussions and interviews with young women scientists to fully understand the challenges and opportunities they currently face within their careers, as well as to hear from them on the elements of an ideal leadership program that can help them address some of the challenges they face. We want to build a program primarily based around their needs and aspirations.

NME: By identifying the barriers and challenges, do you mean that you plan to launch country-specific investigations into how women are faring in the research and development field?

ST: Besides focus group discussions and interviews with the women, the design phase will also include an assessment of current academic programmes on offer in the region and whether these programmes cater to leadership development among graduates. There will also be an assessment of regional and international capacity building programmes to leverage learning and best practices.

During the coming months, a gender expert, a leadership expert and an expert in training activities will gather to prepare modules and produce a detailed framework of the leadership programme incorporating the results of the various assessments.

NME: I can imagine that women in a country like Egypt would be facing starkly different challenges than, say, the women of the United Arab Emirates …

ST: We do have a unique understanding of the region and the differences that exist between the different countries, specifically when it comes to research and development. Our focus group sessions will be divided among three sub-regions (the Gulf, the Levant and North Africa) in order to cater to the differences among the regions and target countries.

NME: How do you plan to measure progress?

ST: Measuring short-term results will include references to quantity and quality of workshops, participant feedback, network reach and similar metrics. Measuring long-terms results and impact will consider the number of women leaders over time in research institutions in the region, and the increase in number of scientific publications of women scientists.

Beating cancer with smarter use of radiation?

This is a guest post by Nature Middle East writer Hebah Salama.

Cancers infect different tissues, and so they manifest differently, in various types, and require different treatments or sometimes a combination of treatments. Throw in variability among patients as a factor, and it’s even more complicated. It’s the reason why numerous studies are carried out every year to try and gauge the most effective therapy for different cancer types.

Now, researchers from Sudan and Lebanon specializing in medical physics and biochemistry have collaborated together on one such study. Their research deals with cancer cases in children, specifically analyzing the effect of different single radiation doses of X-rays on Rhabdomyosarcoma (RMS) – a malignant tumor involving skeletal muscle tissue.

Radiation, one of the most commonly used methods of cancer treatment, is known to cause damage in both healthy and cancerous tissue. It’s what sparked the known risk-benefit-ratio debate on whether the benefits from radiation therapy outweigh the harms. Scientists often discuss the different methods in which radiation can be used while keeping its side-effects to a minimum. As well, new technologies that provide high accuracy in dose delivery have been invented for this purpose; sparing healthy cells.

In this study, the scientists treated cultured RMS cells in vitro (outside of the human body) with therapeutic X-rays. The cells have shown to be resistant to radiation. Additionally, and depending on the radiation dosages, many of the treated cells have repaired from the X-rays’ radiation damage.

The scientists use this study to demonstrate that efforts put into studying tumors’ and healthy tissues’ biological responses to radiation based on tumor type should be stepped up. The more accurate the data provided about these types of responses, the better the outcome of patient treatment is.

“The advancement in technology should be met with more scientific research,” says Alexander Fadul lead researcher.

He adds that more patient oriented studies are certainly needed to determine the different parameters of radiation.

Calgary Depression Scale for Schizophrenia, in Arabic

Scientists from Qatar and the United States have managed to validate an Arabic version of the Calgary Depression Scale for Schizophrenia (CDSS) among patients with schizophrenia.

Schizophrenics commonly show both depressive and negative symptoms that can affect the prognosis and course of their treatment. Negative symptoms are disabling symptoms that have a major impact on the quality of life of patients, more so than positive symptoms, which are thought patterns and behaviors that patients acquire after they become ill.

Tests such as CDSS are designed to distinguish between depression, and negative symptoms that are distinctive of schizophrenia.

These tests are not diagnostic per se, “but they are mainly there to asses the severity of psychotic symptoms in schizophrenia and the possible associated depressive symptoms (using CDSS),” explains Hassen Al-Amin, professor of psychiatry at Weill Cornell Medicine-Qatar and corresponding author of the study that validated the psychiatric test.

“They are significant because they can help us know how sick these patients are and also to monitor how they are responding to treatment with time,” he says.

These types of tests have been used worldwide and their validity is established.

In order to make them work for Arab populations, experts and researchers had to translate the material thoroughly and decide the appropriate cultural equivalents in Arabic. “We then test the Arabic versions with Arab patients with schizophrenia and compare them with those obtained internationally to make sure that we have a valid scale that is culturally acceptable also,” says Al-Amin.

UAE’s green city grabs the attention of international researchers

Masdar city, in the heart of the Gulf desert, on the outskirts of Abu Dhabi, has no light switches or water taps. In Masdar, movement sensors control lighting and water in order to cut down electricity and water consumption by nearly half. The city is touted by the UAE as possibly “one of the world’s most sustainable eco-cities.”

And now University of Birmingham researchers are presenting it as a model to teach the UK and the world about saving energy and resources, contrasting it with energy systems in Birmingham, United Kingdom.

They analyzed the differences and similarities between Masdar, founded very recently in 2008 against an urban environment, and Birmingham, a well-established post-industrial city that has evolved over 400 years. “Masdar City benefits from starting from a blank slate, whereas Birmingham has existing processes, procedures and an ageing infrastructure to negotiate,” according to the researchers.

Masdar is primarily powered by Shams 1, one of the largest concentrated solar power plants in the Middle East, and it houses the Masdar Institute of Science and Technology, which carries out renewable energy research.

“We compared two very different cities – both aspiring to be ‘low-carbon’. Masdar has started well by building low-rise, energy-efficient buildings with smart metering,” says lead author Susan Lee, from the department of civil engineering. “Data from such buildings can help to change people’s behaviour and help develop more energy-efficient new and retrofitted UK buildings. The UAE is a hot and arid place; experience gained in Masdar will help us plan here in the UK for projected hotter summers, with more frequent heatwaves, particularly in cities, as the climate changes.”

Birmingham, says the researcher, has a few things to teach Masdar as well, including how the city adapted to new energy requirements. Lee believes that Masdar can also benefit from her university’s research into hydrogen fuel-cell cars.